SCHEMBL15540445

SCHEMBL15540445

CC(C)(F)CN1CCC(COc2ccc(-c3ccc(C(=O)O)cc3)cc2F)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR5 P35346 5/20 0.48
KCNH2 Q12809 1/20 0.48
RBP4 P02753 2/20 0.44
TTR P02766 1/20 0.44
MAP4K4 O95819 1/20 0.44
FFAR1 O14842 1/20 0.40
PPARD Q03181 1/20 0.40
FFAR4 Q5NUL3 4/20 0.40
ESR1 P03372 2/20 0.39
CYP2C8 P10632 1/20 0.39
CYP2B6 P20813 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
RARA P10276 1/20 0.38
RARB P10826 1/20 0.38
RARG P13631 1/20 0.38
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
HSD17B10 Q99714 1/20 0.38
WNT1 P04628 1/20 0.38
GSK3B P49841 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15540254 0.91 RBP4 (0.44) SSTR5KCNH2RBP4TTRPPARD
SCHEMBL15538921 0.90 CHRM4 (0.43) SSTR5KCNH2RBP4TTRFFAR4
SCHEMBL15538448 0.90 CHRM4 (0.43) SSTR5KCNH2RBP4FFAR1PPARD
SCHEMBL15539960 0.87 XDH (0.53) SSTR5KCNH2MAP4K4
SCHEMBL15539556 0.87 DYRK1A (0.43) SSTR5KCNH2RBP4TTRPPARD
SCHEMBL15538558 0.85 HRH3 (0.43) RBP4TTRHRH3
SCHEMBL16803843 0.85 SMN1; SMN2 (0.47) HRH3LMNAWNT1GSK3BDYRK1A
SCHEMBL15538562 0.85 HRH3 (0.43) RBP4TTRHRH3
SCHEMBL15537615 0.85 SSTR5 (0.55) SSTR5KCNH2RARB
SCHEMBL15538824 0.84 CHRM2 (0.42) RBP4FFAR4HRH3WNT1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2858986-B1 PIPERIDINE DERIVATIVES AS GPR119 AGONISTS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2019-10-30 EP disclosed
US-9944600-B2 Piperidine derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2018-04-17 US disclosed
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-06-18 US disclosed
EP-2858986-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST Chong Kun Dang Pharmaceutical Corp. (KR) 2015-04-15 EP disclosed
WO-2013187646-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2013-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST GPR119, FFAR2, GPR84 SSTR5 104/4885KCNH2 680/4885RBP4 2215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.